Literature DB >> 21441448

A novel leukocyte adhesion deficiency III variant: kindlin-3 deficiency results in integrin- and nonintegrin-related defects in different steps of leukocyte adhesion.

Philippe Robert1, Matthias Canault, Catherine Farnarier, Alan Nurden, Charlotte Grosdidier, Vincent Barlogis, Pierre Bongrand, Anne Pierres, Hervé Chambost, Marie-Christine Alessi.   

Abstract

Leukocyte adhesion deficiency type III is a recently described condition involving a Glanzmann-type bleeding syndrome and leukocyte adhesion deficiency. This was ascribed to a defect of the FERMT3 gene resulting in abnormal expression of kindlin-3, a protein expressed in hematopoietic cells with a major role in the regulation of integrin activation. In this article, we describe a patient with a new mutation of FERMT3 and lack of kindlin-3 expression in platelets and leukocytes. We assayed quantitatively the first steps of kindlin-3-defective leukocyte adhesion, namely, initial bond formation, bond strengthening, and early spreading. Initial bond formation was readily stimulated with neutrophils stimulated by fMLF, and neutrophils and lymphocytes stimulated by a phorbol ester or Mn(2+). In contrast, attachment strengthening was defective in the patient's lymphocytes treated with PMA or Mn(2+), or fMLF-stimulated neutrophils. However, attachment strengthening was normal in patient's neutrophils treated with phorbol ester or Mn(2+). In addition, the patient's T lymphocytes displayed defective integrin-mediated spreading and a moderate but significant decrease of spreading on anti-CD3-coated surfaces. Patient's neutrophils displayed a drastic alteration of integrin-mediated spreading after fMLF or PMA stimulation, whereas signaling-independent Mn(2+) allowed significant spreading. In conclusion, the consequences of kindlin-3 deficiency on β(2) integrin function depend on both cell type and the stimulus used for integrin activation. Our results suggest looking for a possible kindlin-3 involvement in membrane dynamical event independent of integrin-mediated adhesion.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21441448     DOI: 10.4049/jimmunol.1003141

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  24 in total

Review 1.  Hematologically important mutations: leukocyte adhesion deficiency (first update).

Authors:  Edith van de Vijver; Anne Maddalena; Özden Sanal; Steven M Holland; Gulbu Uzel; Manisha Madkaikar; Martin de Boer; Karin van Leeuwen; M Yavuz Köker; Nima Parvaneh; Alain Fischer; S K Alex Law; Nigel Klein; F Ilhan Tezcan; Ekrem Unal; Turkan Patiroglu; Bernd H Belohradsky; Klaus Schwartz; Raz Somech; Taco W Kuijpers; Dirk Roos
Journal:  Blood Cells Mol Dis       Date:  2011-11-30       Impact factor: 3.039

2.  Procoagulant platelets form an α-granule protein-covered "cap" on their surface that promotes their attachment to aggregates.

Authors:  Anastasia A Abaeva; Matthias Canault; Yana N Kotova; Sergey I Obydennyy; Alena O Yakimenko; Nadezhda A Podoplelova; Vladimir N Kolyadko; Herve Chambost; Aleksei V Mazurov; Fazoil I Ataullakhanov; Alan T Nurden; Marie-Christine Alessi; Mikhail A Panteleev
Journal:  J Biol Chem       Date:  2013-08-30       Impact factor: 5.157

Review 3.  Leukocyte adhesion deficiency III - when integrins activation fails.

Authors:  Amos Etzioni
Journal:  J Clin Immunol       Date:  2014-09-20       Impact factor: 8.317

Review 4.  When Actin is Not Actin' Like It Should: A New Category of Distinct Primary Immunodeficiency Disorders.

Authors:  Evelien G G Sprenkeler; Steven D S Webbers; Taco W Kuijpers
Journal:  J Innate Immun       Date:  2020-08-26       Impact factor: 7.349

Review 5.  Long-term management of leukocyte adhesion deficiency type III without hematopoietic stem cell transplantation.

Authors:  Paul Saultier; Sarah Szepetowski; Matthias Canault; Céline Falaise; Marjorie Poggi; Pierre Suchon; Vincent Barlogis; Gérard Michel; Stéphane Loyau; Martine Jandrot-Perrus; Jean-Claude Bordet; Marie-Christine Alessi; Hervé Chambost
Journal:  Haematologica       Date:  2018-02-22       Impact factor: 9.941

6.  Allogeneic hematopoietic stem cell transplantation in leukocyte adhesion deficiency type I and III.

Authors:  Shahrzad Bakhtiar; Emilia Salzmann-Manrique; Henric-Jan Blok; Dirk-Jan Eikema; Sheree Hazelaar; Mouhab Ayas; Amos Toren; Gal Goldstein; Despina Moshous; Franco Locatelli; Pietro Merli; Gerard Michel; Gülyüz Öztürk; Ansgar Schulz; Carsten Heilmann; Marianne Ifversen; Rob F Wynn; Olga Aleinikova; Yves Bertrand; Abdelghani Tbakhi; Paul Veys; Musa Karakukcu; Alphan Kupesiz; Ardeshir Ghavamzadeh; Rupert Handgretinger; Emel Unal; Antonio Perez-Martinez; Muge Gokce; Fulvio Porta; Tekin Aksu; Gülsün Karasu; Isabel Badell; Per Ljungman; Elena Skorobogatova; Akif Yesilipek; Tsila Zuckerman; Robbert R G Bredius; Polina Stepensky; Bella Shadur; Mary Slatter; Andrew R Gennery; Michael H Albert; Peter Bader; Arjan Lankester
Journal:  Blood Adv       Date:  2021-01-12

7.  Leukocyte adhesion deficiency-I variant syndrome (LAD-Iv, LAD-III): molecular characterization of the defect in an index family.

Authors:  Estelle S Harris; Tammy L Smith; Gregory M Springett; Andrew S Weyrich; Guy A Zimmerman
Journal:  Am J Hematol       Date:  2011-12-03       Impact factor: 10.047

8.  ADAP interactions with talin and kindlin promote platelet integrin αIIbβ3 activation and stable fibrinogen binding.

Authors:  Ana Kasirer-Friede; Jian Kang; Bryan Kahner; Feng Ye; Mark H Ginsberg; Sanford J Shattil
Journal:  Blood       Date:  2014-02-12       Impact factor: 22.113

Review 9.  Lessons from rare maladies: leukocyte adhesion deficiency syndromes.

Authors:  Estelle S Harris; Andrew S Weyrich; Guy A Zimmerman
Journal:  Curr Opin Hematol       Date:  2013-01       Impact factor: 3.284

Review 10.  Profiling the Genetic and Molecular Characteristics of Glanzmann Thrombasthenia: Can It Guide Current and Future Therapies?

Authors:  Alan Nurden
Journal:  J Blood Med       Date:  2021-07-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.